Investigación / Grupos de investigación

Grupo  27

Farmacia Hospitalaria y Farmacogenómica

Publicaciones (387)

  • Parra, AP; Ramos, N; Perurena-Prieto, J; Manrique-Rodríguez, S; Climente, M; Quintanilla, LG; Escolano, A; Miarons, M.

    [Translated article] Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy

    FARMACIA HOSPITALARIA. 2024; 48(1): 16-22 [doi:10.1016/j.farma.2023.09.009]

  • Escudero-Vilaplana, V; Collado-Borrell, R; De Castro, J; Insa, A; Martinez, A; Fernandez, E; Sullivan, I; Flores, A; Arrabal, N; Carcedo, D; Manzaneque, A.

    Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1

    Journal of Medical Economics. 2023; 26(1): 445-453 Nº de citas: 4 [doi:10.1080/13696998.2023.2188844]

  • Valerio, M; Veintimilla, C; Rodriguez, C; de la Villa, S; Sanchez-Somolinos, M; Cerezales, M; Crespo, C; Rodriguez, S; Adan, I; Chamorro, E; Rossello, I; Munoz, P.

    Cost analysis of disease including treatment with dalbavancin in a Spanish hospital: ECODAL ANALYSIS

    Journal of Medical Economics. 2023; 26(1): 463-472 Nº de citas: 4 [doi:10.1080/13696998.2023.2190704]

  • Martinez-Moragon, E; Ercoreca, IA; Garcia, MM; Maldonado, FC; Lamas, MC; Vives, EC; Diz, CC; Diaz-Perez, D; Gracia, IE; Gil, SG; Gonzalez-Perez, R; Mena, AH; Valverde, TH; Montana, SJ; Lopez-Carrasco, V; Lopez, IM; Merino-Bohorquez, V; Moreno-Ancillo, A; Cabeza, ACM; Monte-Boquet, E; Revuelta-Herrero, JL; Sanchez-Cuellar, S.

    Patient-reported outcome measures in severe asthma: an expert consensus

    JOURNAL OF ASTHMA. 2023; 61(6): 619-631 Nº de citas: 3 [doi:10.1080/02770903.2023.2297372]

  • Costas, DG; Sánchez, AR; Manzorro, AG; Martinez, IG; Fernandez, FJS; Sanz, BT; Bermejo, SH; Herranz-Alonso, AM; Sanjurjo, M.

    Impact of preoperative pharmaceutical care consultation on medication errors in surgical patients: a comprehensive analysis

    EXPERT OPINION ON DRUG SAFETY. 2023; 22: 1301-1307 Nº de citas: 2 [doi:10.1080/14740338.2023.2292710]

  • Cuervas-Mons Vendrell M; Iturgoyen Fuentes DP; Arrojo Suárez J; Jimenez Lozano I; Fernandez-Llamazares CM; Tristancho-Perez A; Yunquera Romero L; Martínez Roca C; Otero Villalustre C; García Robles A; Garrido Corro B; Rodríguez Marrodán B.

    Medication reconciliation on admission in paediatric chronic patients: A multicentre study.

    Anales De Pediatria. 2023; 99(6): 376-384 [doi:10.1016/j.anpede.2023.11.008]

  • Vendrell, MCM; Fuentes, DPI; Suárez, JA; Lozano, IJ; Fernandez-Llamazares, CM; Tristancho-Perez, A; Romero, LY; Roca, CM; Villalustre, CO; Robles, AG; Corro, BG; Marrodán, BR.

    Medication reconciliation at admission in paediatric patients with chronic illness: A multicentre study

    ANALES DE PEDIATRIA. 2023; 99(6): 376-384 [doi:10.1016/j.anpedi.2023.10.004]

  • Vendrell, MCM; Fuentes, DPI; Flaque, MV; Poy, MJC; Fernandez-Llamazares, CM; Del Vayo, CA; Fernandez, CG; Roca, CM; Gago, YH; Robles, AG; Corro, BG.

    [Translated article] Medication reconciliation in pediatric hemato-oncologic patients: A multicenter study

    FARMACIA HOSPITALARIA. 2023; 47(6): 261-267 [doi:10.1016/j.farma.2023.07.012]

  • Vendrell, MCM; Fuentes, DPI; Flaque, MV; Poy, MJC; Fernández-Llamazares, CM; Vayo, CAD; Fernández, CG; Roca, CM; Gago, YH; Robles, AG; Corro, BG.

    Multicentre study of medication reconciliation in paediatric onco-hematology

    FARMACIA HOSPITALARIA. 2023; 47(6): 261-267 [doi:10.1016/j.farma.2023.06.004]

  • Lozano-Ros, A; Martínez-Ginés, ML; García-Domínguez, JM; Salvador-Martín, S; Goicochea-Briceño, H; Cuello, JP; Meldaña-Rivera, A; Higueras-Hernández, Y; Sanjurjo-Sáez, M; Alvarez-Sala-Walther, LA; López-Fernández, LA.

    Changes in the Expression of TGF-Beta Regulatory Pathway Genes Induced by Vitamin D in Patients with Relapsing-Remitting Multiple Sclerosis

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(19): Nº de citas: 5 [doi:10.3390/ijms241914447]

  • Guisado-Gil, AB; Gutiórrez-Urbón, JM; Ribed-Sánchez, A; Luque-Pardos, S; Sánchez-Cadena, A; Mejuto, B; Jaramillo-Ruiz, D; Peñalva, G; Cisneros, JM.

    [Translated article] Analysis of the appropriateness of antibiotic prophylaxis in surgical procedures in Spain. Protocol for the "ProA-Q" study

    FARMACIA HOSPITALARIA. 2023; 47(5): 224-229 [doi:10.1016/j.farma.2023.07.003]

  • Guisado-Gil, AB; Gutiérrez-Urbón, JM; Ribed-Sánchez, A; Luque-Pardos, S; Sánchez-Cadena, A; Mejuto, B; Jaramillo-Ruiz, D; Peñalva, G; Cisneros, JM.

    Analysis of the appropriateness of antibiotic prophylaxis in surgical procedures in Spain. Protocol for the "ProA-Q" study

    FARMACIA HOSPITALARIA. 2023; 47(5): 224-229 [doi:10.1016/j.farma.2023.05.002]

  • Vicente-Valor, J; Rodriguez-Gonzalez, C; Ferris-Villanueva, M; Chamorro-de-Vega, E; Romero-Jimenez, R; Gomez-Costas, D; Herrero-Bermejo, S; Tejerina-Picado, F; Osorio-Prendes, S; Oarbeascoa-Royuela, G; Herranz-Alonso, A; Sanjurjo-Saez, M.

    Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study

    PHARMACOLOGICAL REPORTS. 2023; 75(5): 1254-1264 Nº de citas: 1 [doi:10.1007/s43440-023-00519-8]

  • Ramos-Ruperez, E; Escudero-Vilaplana, V; Ruiz-Briones, P; Collado-Borrell, R; Villanueva-Bueno, C; Revuelta-Herrero, JL; Gonzalez-Haba, E; Garcia-Gonzalez, X; Ibanez-Garcia, S; Perez-Ramirez, S; Zatarain-Nicolas, E; Herranz, A; Sanjurjo, M.

    Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy

    Frontiers in Oncology. 2023; 13: Nº de citas: 2 [doi:10.3389/fonc.2023.1220305]

  • Yuste, I; Luciano, FC; Anaya, BJ; Sanz-Ruiz, P; Ribed-Sanchez, A; Gonzalez-Burgos, E; Serrano, DR.

    Engineering 3D-Printed Advanced Healthcare Materials for Periprosthetic Joint Infections

    Antibiotics-Basel. 2023; 12(8): [doi:10.3390/antibiotics12081229]

  • Bermejo-Gomez, A; Aguilera-Alonso, D; Rincon-Lopez, EM; Catalan-Alonso, P; Bardon-Cancho, EJ; Garcia-Morin, M; Manrique-Rodriguez, S; Navarro-Gomez, ML.

    Use of Monoclonal Antibodies in a Pediatric Patient With Severe Combined Immunodeficiency and Persistent SARS-CoV-2 Infection

    PEDIATRIC INFECTIOUS DISEASE JOURNAL. 2023; 42(8): 290-292 [doi:10.1097/INF.0000000000003938]

  • Zapata-Cobo P; Salvador-Martín S; Velasco M; Palomino LM; Clemente S; Segarra O; Moreno-Álvarez A; Fernández-Lorenzo A; Pérez-Moneo B; Montraveta M; Sánchez C; Tolín M; Loverdos I; Fobelo MJ; Navas-López VM; Magallares L; García-Romero R; Sánchez-Hernández JG; Rodríguez A; Bossacoma F; Balboa MJ; Salcedo E; Sanjurjo-Sáez M; López-Fernández LA.

    Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.

    PHARMACOLOGICAL RESEARCH. 2023; 194: 106859-106859 Nº de citas: 5 [doi:10.1016/j.phrs.2023.106859]

  • Beatriz GC; María José O; Inés JL; Yolanda HG; Concha ÁD; Javier TS; Cecilia M FL.

    Medication errors in children visiting pediatric emergency departments.

    FARMACIA HOSPITALARIA. 2023; 47(4): [doi:10.1016/j.farma.2023.06.001]